Related Experiment Videos

Pathogenicity of Hansenula anomala in model of immunocompromised mice

J R Cermeño-Vivas1, J M Torres-Rodríguez, J M Corominas

  • 1Department of Parasitology and Microbiology, Universidad de Oriente, Ciudad Bolívar, Venezuela.

Mycopathologia
|September 11, 1999
PubMed

Insights

Opportunistic fungal infections are rising, especially in immunocompromised individuals. This study found Hansenula anomala has low pathogenicity in immunocompromised mice compared to Candida albicans.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Systemic fungal infections by opportunistic pathogens are increasing, particularly in immunocompromised patients.
  • Hansenula anomala, a yeast, is part of the normal flora but its pathogenic potential is under investigation.
  • Candida albicans serves as a benchmark for fungal pathogenicity studies.

Purpose of the Study:

  • To compare the pathogenicity of Hansenula anomala and Candida albicans in an experimental model.
  • To evaluate H. anomala's infection potential in immunocompromised mice.

Main Methods:

  • Swiss mice were immunosuppressed using cyclophosphamide and treated with amoxicillin/clavulanic acid.
  • Mice were inoculated with H. anomala or Candida albicans.
  • Histological and mycological analyses were performed on tissue samples from multiple organs.

Main Results:

  • H. anomala primarily infected kidneys and liver (20%), and lungs (10%) under standard immunosuppression.
  • Under sustained immunosuppression, H. anomala was detected in 65.5% of examined organs.
  • The study established a comparative model for fungal pathogenicity.

Conclusions:

  • Hansenula anomala demonstrated low pathogenicity in the experimental model of immunocompromised mice.
  • Further research is needed to understand the clinical significance of H. anomala in immunocompromised individuals.

Related Concept Videos